Literature DB >> 26496506

Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry.

Wolfgang Schaefer1, Hans R Völger1, Stefan Lorenz1, Sabine Imhof-Jung1, Jörg T Regula1, Christian Klein2, Michael Mølhøj1.   

Abstract

The quadroma antibody represents the first attempt to produce a bispecific heterodimeric IgG antibody by somatic fusion of 2 hybridoma cells each expressing monoclonal antibodies with distinctive specificities. However, because of random heavy and light chain pairing, the desired functional bispecific antibody represents only a small fraction of the protein produced. Subsequently, the knobs-into-holes (KiH) approach was developed to enforce correct heavy chain heterodimerization. Assuming equimolar expression of 4 unmodified chains comprising 2 heavy and 2 light chains, the statistical distribution of all paired combinations can be calculated. With equimolar expression as the goal, we transfected HEK cells with 1:1:1:1 plasmid ratios and analyzed the protein A affinity-purified antibodies from the quadroma and KiH approaches qualitatively and quantitatively with regard to the estimated relative amounts of the products using electrospray quadrupole time-of-flight mass spectrometry. Our results show that all expected species are formed, and that, within the methodological limits, the species distribution in the mixtures corresponds approximately to the statistical distribution.

Keywords:  CrossMab; ESI-QTOF mass spectrometry; bispecific antibody; chain pairing; knobs-into-holes; quadroma

Mesh:

Substances:

Year:  2015        PMID: 26496506      PMCID: PMC4966523          DOI: 10.1080/19420862.2015.1111498

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  35 in total

1.  Improving biophysical properties of a bispecific antibody scaffold to aid developability: quality by molecular design.

Authors:  Thomas Spreter Von Kreudenstein; Eric Escobar-Carbrera; Paula I Lario; Igor D'Angelo; Karine Brault; John Kelly; Yves Durocher; Jason Baardsnes; R Jeremy Woods; Michael Hongwei Xie; Pierre-Alain Girod; Michael D L Suits; Martin J Boulanger; David K Y Poon; Gordon Y K Ng; Surjit B Dixit
Journal:  MAbs       Date:  2013-07-08       Impact factor: 5.857

2.  'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization.

Authors:  J B Ridgway; L G Presta; P Carter
Journal:  Protein Eng       Date:  1996-07

Review 3.  Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies.

Authors:  Christian Klein; Claudio Sustmann; Markus Thomas; Kay Stubenrauch; Rebecca Croasdale; Jürgen Schanzer; Ulrich Brinkmann; Hubert Kettenberger; Jörg T Regula; Wolfgang Schaefer
Journal:  MAbs       Date:  2012-08-27       Impact factor: 5.857

4.  A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties.

Authors:  Thomas Tiller; Ingrid Schuster; Dorothée Deppe; Katja Siegers; Ralf Strohner; Tanja Herrmann; Marion Berenguer; Dominique Poujol; Jennifer Stehle; Yvonne Stark; Martin Heßling; Daniela Daubert; Karin Felderer; Stefan Kaden; Johanna Kölln; Markus Enzelberger; Stefanie Urlinger
Journal:  MAbs       Date:  2013-04-09       Impact factor: 5.857

5.  A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism.

Authors:  Zhi Liu; Esther C Leng; Kannan Gunasekaran; Martin Pentony; Min Shen; Monique Howard; Janelle Stoops; Kathy Manchulenko; Vladimir Razinkov; Hua Liu; William Fanslow; Zhonghua Hu; Nancy Sun; Haruki Hasegawa; Rutilio Clark; Ian N Foltz; Wei Yan
Journal:  J Biol Chem       Date:  2015-01-12       Impact factor: 5.157

6.  Bispecific monoclonal antibodies from hybrid hybridomas.

Authors:  M R Suresh; A C Cuello; C Milstein
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

7.  VH/VL interface engineering to promote selective expression and inhibit conformational isomerization of thrombopoietin receptor agonist single-chain diabody.

Authors:  Tomoyuki Igawa; Hiroyuki Tsunoda; Yasufumi Kikuchi; Maki Yoshida; Megumi Tanaka; Akiko Koga; Yasuo Sekimori; Tetsuro Orita; Yoshinori Aso; Kunihiro Hattori; Masayuki Tsuchiya
Journal:  Protein Eng Des Sel       Date:  2010-06-24       Impact factor: 1.650

8.  Structural basis for the preferential association of autologous immunoglobulin subunits: role of the J region of the light chain.

Authors:  P A Hamel; D E Isenman; M H Klein; R Luedtke; K J Dorrington
Journal:  Mol Immunol       Date:  1984-04       Impact factor: 4.407

9.  Development of a two-part strategy to identify a therapeutic human bispecific antibody that inhibits IgE receptor signaling.

Authors:  Janet Jackman; Yongmei Chen; Arthur Huang; Barbara Moffat; Justin M Scheer; Steven R Leong; Wyne P Lee; Juan Zhang; Navneet Sharma; Yanmei Lu; Suhasini Iyer; Robert L Shields; Nancy Chiang; Michele C Bauer; Diana Wadley; Merone Roose-Girma; Richard Vandlen; Daniel G Yansura; Yan Wu; Lawren C Wu
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

10.  Immunoglobulins secreted by a hybrid-hybridoma: analysis of chain assemblies.

Authors:  W Smith; A L Jarrett; R E Beattie; J R Corvalan
Journal:  Hybridoma       Date:  1992-02
View more
  7 in total

Review 1.  The making of bispecific antibodies.

Authors:  Ulrich Brinkmann; Roland E Kontermann
Journal:  MAbs       Date:  2017 Feb/Mar       Impact factor: 5.857

2.  Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells.

Authors:  Michael Dillon; Yiyuan Yin; Jianhui Zhou; Luke McCarty; Diego Ellerman; Dionysos Slaga; Teemu T Junttila; Guanghui Han; Wendy Sandoval; Meric A Ovacik; Kedan Lin; Zhilan Hu; Amy Shen; Jacob E Corn; Christoph Spiess; Paul J Carter
Journal:  MAbs       Date:  2016-12-08       Impact factor: 5.857

Review 3.  The use of CrossMAb technology for the generation of bi- and multispecific antibodies.

Authors:  Christian Klein; Wolfgang Schaefer; Jörg T Regula
Journal:  MAbs       Date:  2016-06-10       Impact factor: 5.857

4.  Precise quantification of mixtures of bispecific IgG produced in single host cells by liquid chromatography-Orbitrap high-resolution mass spectrometry.

Authors:  Yiyuan Yin; Guanghui Han; Jianhui Zhou; Michael Dillon; Luke McCarty; Lou Gavino; Diego Ellerman; Christoph Spiess; Wendy Sandoval; Paul J Carter
Journal:  MAbs       Date:  2016-09-09       Impact factor: 5.857

5.  When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions.

Authors:  Andrew R M Bradbury; Nathan D Trinklein; Holger Thie; Ian C Wilkinson; Atul K Tandon; Stephen Anderson; Catherine L Bladen; Brittany Jones; Shelley Force Aldred; Marco Bestagno; Oscar Burrone; Jennifer Maynard; Fortunato Ferrara; James S Trimmer; Janina Görnemann; Jacob Glanville; Philipp Wolf; Andre Frenzel; Julin Wong; Xin Yu Koh; Hui-Yan Eng; David Lane; Marie-Paule Lefranc; Mike Clark; Stefan Dübel
Journal:  MAbs       Date:  2018-03-29       Impact factor: 5.857

6.  Variable heavy-variable light domain and Fab-arm CrossMabs with charged residue exchanges to enforce correct light chain assembly.

Authors:  Joerg Thomas Regula; Sabine Imhof-Jung; Michael Mølhøj; Joerg Benz; Andreas Ehler; Alexander Bujotzek; Wolfgang Schaefer; Christian Klein
Journal:  Protein Eng Des Sel       Date:  2018-07-01       Impact factor: 1.650

7.  Novel CH1:CL interfaces that enhance correct light chain pairing in heterodimeric bispecific antibodies.

Authors:  Maximilian Bönisch; Carolin Sellmann; Daniel Maresch; Claudia Halbig; Stefan Becker; Lars Toleikis; Björn Hock; Florian Rüker
Journal:  Protein Eng Des Sel       Date:  2017-09-01       Impact factor: 1.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.